본문으로 건너뛰기
← 뒤로

Fulminant Fournier gangrene in bladder cancer: case report and review of the literature.

증례보고 1/5 보강
European review for medical and pharmacological sciences 📖 저널 OA 3% 2021: 0/3 OA 2022: 0/6 OA 2023: 2/20 OA 2024: 0/6 OA 2025: 0/5 OA 2026: 0/4 OA 2021~2026 2026 Vol.30(1) p. 46-50
Retraction 확인
출처

De Felice M, Tammaro M, Caterino M, Nacca V, Cangiano R

📝 환자 설명용 한 줄

[BACKGROUND] The introduction of new target therapies and immunotherapy combinations has dramatically improved the prognosis of cancer patients.

이 논문을 인용하기

↓ .bib ↓ .ris
APA De Felice M, Tammaro M, et al. (2026). Fulminant Fournier gangrene in bladder cancer: case report and review of the literature.. European review for medical and pharmacological sciences, 30(1), 46-50. https://doi.org/10.26355/eurrev_202601_37648
MLA De Felice M, et al.. "Fulminant Fournier gangrene in bladder cancer: case report and review of the literature.." European review for medical and pharmacological sciences, vol. 30, no. 1, 2026, pp. 46-50.
PMID 41636293 ↗

Abstract

[BACKGROUND] The introduction of new target therapies and immunotherapy combinations has dramatically improved the prognosis of cancer patients. Surgery and radiotherapy currently represent the cornerstones of loco-regional management, both for palliative and curative purposes. It is no coincidence, therefore, that in recent years the frequency of complications once considered rare has increased.

[CASE REPORT] Here we present the case of a patient affected by metastatic bladder cancer whose treatments (surgery, radiotherapy, and targeted therapy) favored a rapid and acute onset of Fournier syndrome. The fulminant course prevented the establishment of a potentially effective treatment.

[CONCLUSIONS] Fournier gangrene is an acute perineal necrosis caused by anaerobic bacteria. Management is complex and requires a quick multidisciplinary approach, even though, among cancer patients, mortality is very high.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반